Brook.ai, an innovator in remote patient care, has secured $28 million in Series B financing to accelerate its national expansion and further advance its outcomes-driven model for continuous healthcare delivery. The funding round was co-led by UMass Memorial Health and Morningside, reflecting growing confidence in Brook’s ability to improve patient outcomes and address systemic healthcare challenges.
The investment comes at a time of rapid transformation within the U.S. healthcare system as providers shift toward value-based care and at-home models. Brook.ai’s platform integrates artificial intelligence with clinical expertise to deliver continuous, personalized patient engagement — offering an extension of care beyond the clinic walls. The company’s results with healthcare partners have been significant, including a 90% reduction in congestive heart failure readmissions and an 80% increase in controlled hypertension populations within six weeks.
The platform’s strong patient engagement has fueled Brook’s growth, with a 204% year-over-year increase in patients, an 82% retention rate, and a Net Promoter Score of 66 — a level categorized as “excellent.” These indicators point to the platform’s sustained adoption by patients and providers alike.
The new capital will be directed toward expanding services for additional patient populations, advancing AI capabilities, increasing product and engineering headcount, enhancing platform engagement, and scaling operations to support growing demand. Brook’s solution, which health systems can implement within 30 days and without capital expenditure, aims to reduce operational burdens by handling infrastructure, staffing, and billing complexities on behalf of its partners.
By combining intelligent data analytics with compassionate clinical support, Brook.ai provides a scalable and equitable model for continuous, outcomes-driven care that benefits patients, providers, and payers.
KEY QUOTES:
“At UMass Memorial, we’ve seen firsthand how Brook’s remote care model improves patient outcomes and supports population health. That’s why we’re proud to lead this investment and expand our use of the platform, helping scale a solution that delivers continuous care at a critical moment for health systems. Our goal is to back models that expand access, improve equity, and strengthen the sustainability of care for our patients and community.”
— Eric Dickson, MD, President and CEO, UMass Memorial Health
“Outcomes-focused support makes a real difference for patients and providers, and what really sets Brook apart is that people actually use our platform at home, every day. That engagement drives better outcomes and growth, as shown by the ongoing expansion we see with our customers and investors. Our partnership with UMass Memorial and Morningside in our latest investment round allows us to expand our outcomes-driven model to more health systems at a moment when it’s needed most.”
— Oren Nissim, CEO, Brook.ai
“Brook’s ability to deliver robust clinical outcomes while also creating clear benefits to its health system partners has created a truly differentiated platform, and we are proud to be co-leading with UMass Memorial on this investment. This round will enable Brook to continue scaling its commercial activities while also expanding its clinical reach to become even more impactful to our partners.”
— Stephen Bruso, Morningside
